Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
3.460
+0.070 (2.06%)
At close: May 19, 2026, 4:00 PM EDT
3.460
0.00 (0.00%)
After-hours: May 19, 2026, 7:36 PM EDT
Iovance Biotherapeutics Employees
Iovance Biotherapeutics had 975 employees as of December 31, 2025. The number of employees increased by 137 or 16.35% compared to the previous year.
Employees
975
Change (1Y)
137
Growth (1Y)
16.35%
Revenue / Employee
$292,931
Profits / Employee
-$362,933
Market Cap
1.54B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 975 | 137 | 16.35% |
| Dec 31, 2024 | 838 | 281 | 50.45% |
| Dec 31, 2023 | 557 | 54 | 10.74% |
| Dec 31, 2022 | 503 | 184 | 57.68% |
| Dec 31, 2021 | 319 | 78 | 32.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Novavax | 749 |
| Recursion Pharmaceuticals | 600 |
| Ardelyx | 489 |
| Vir Biotechnology | 367 |
| Nuvation Bio | 307 |
| Monte Rosa Therapeutics | 187 |
| Precigen | 160 |
| Inhibrx Biosciences | 110 |
IOVA News
- 11 days ago - Iovance Biotherapeutics price target lowered to $14 from $16 at Chardan - TheFly
- 12 days ago - Iovance Biotherapeutics reports Q1 EPS (19c), consensus (15c) - TheFly
- 12 days ago - Iovance Biotherapeutics sees Q2 revenue $86M-$88M, consensus $84.36M - TheFly
- 12 days ago - Iovance Biotherapeutics sees FY26 revenue $350M-$370M, consensus $359.68M - TheFly
- 12 days ago - Iovance Biotherapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 12 days ago - Iovance Biotherapeutics Earnings release: Q1 2026 - Filings
- 12 days ago - Iovance Biotherapeutics Quarterly report: Q1 2026 - Filings
- 12 days ago - Iovance Biotherapeutics Highlights Positive First Quarter 2026 Results, Business Achievements and Corporate Updates - GlobeNewsWire